Trial
NCT03623984
Molecular-Guided Surgery for Pancreatic and GI Neuroendocrine Cancers
Early Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Alabama at Birmingham
Collaborators
—
Condition
Neuroendocrine Carcinoma of Pancreas
Intervention
Gallium Dotatate
Why stopped
no partipants
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-09-11